Category: Pα+ - Page 8 - Psychedelic Alpha

Read more about the article Patients, Practitioners, Researchers and Public Submit Comments Ahead of FDA Advisory Committee on MDMA

Patients, Practitioners, Researchers and Public Submit Comments Ahead of FDA Advisory Committee on MDMA

Post published:May 29, 2024
Post category:Analysis Pα+

Read more about the article What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD

What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD

Post published:May 27, 2024
Post category:Analysis Pα+

Read more about the article Pα+ Psychedelic Patent Analysis: April 2024

Pα+ Psychedelic Patent Analysis: April 2024

Post published:May 24, 2024
Post category:Psychedelic Patent Analysis Pα+

Read more about the article Pα+ Psychedelic Bulletin #163: Tempering Excitement Around Recent Raises; Compass Shares Cut of Open-Label PTSD Data; Other News

Pα+ Psychedelic Bulletin #163: Tempering Excitement Around Recent Raises; Compass Shares Cut of Open-Label PTSD Data; Other News

Post published:May 17, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals

Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals

Post published:May 13, 2024
Post category:Analysis News Pα+

Read more about the article European Medicines Agency CMO Talks Psychedelics and Their Therapeutic Use in Live Q&A

European Medicines Agency CMO Talks Psychedelics and Their Therapeutic Use in Live Q&A

Post published:May 9, 2024
Post category:Analysis News Pα+

Read more about the article FDA Advisory Committee to Review Lykos Therapeutics’ MDMA-Assisted Therapy in Early June

FDA Advisory Committee to Review Lykos Therapeutics’ MDMA-Assisted Therapy in Early June

Post published:May 7, 2024
Post category:Analysis News Pα+

Read more about the article Reunion Neuroscience Gets a New Lease of Life with $103M Series A to Fund Phase 2 Studies of 4-HO-DiPT Prodrug

Reunion Neuroscience Gets a New Lease of Life with $103M Series A to Fund Phase 2 Studies of 4-HO-DiPT Prodrug

Post published:May 3, 2024
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Patent Analysis: March 2024

Pα+ Psychedelic Patent Analysis: March 2024

Post published:April 30, 2024
Post category:Psychedelic Patent Analysis Pα+

Read more about the article Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to ICER’s Draft Evidence Report on Lykos’ MDMA; and more…

Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to ICER’s Draft Evidence Report on Lykos’ MDMA; and more…

Post published:April 25, 2024
Post category:Psychedelic Bulletin Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.